497 related articles for article (PubMed ID: 34649356)
1. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
Xiao X; Li H; Zhao L; Zhang Y; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
3. Artificial Intelligence in Aptamer-Target Binding Prediction.
Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
[TBL] [Abstract][Full Text] [Related]
4. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
5. Recent progress of SELEX methods for screening nucleic acid aptamers.
Zhu C; Feng Z; Qin H; Chen L; Yan M; Li L; Qu F
Talanta; 2024 Jan; 266(Pt 1):124998. PubMed ID: 37527564
[TBL] [Abstract][Full Text] [Related]
6. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
7. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
Dausse E; Da Rocha Gomes S; Toulmé JJ
Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
[TBL] [Abstract][Full Text] [Related]
8. Post-SELEX optimization of aptamers.
Gao S; Zheng X; Jiao B; Wang L
Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
[TBL] [Abstract][Full Text] [Related]
9. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Aptamer Discovery and Applications.
Zhang Y; Lai BS; Juhas M
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
[TBL] [Abstract][Full Text] [Related]
11. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
[TBL] [Abstract][Full Text] [Related]
12. A Highlight of Recent Advances in Aptamer Technology and Its Application.
Sun H; Zu Y
Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
[TBL] [Abstract][Full Text] [Related]
13. Current approaches in SELEX: An update to aptamer selection technology.
Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
[TBL] [Abstract][Full Text] [Related]
14. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
[TBL] [Abstract][Full Text] [Related]
15. Aptamers: selection, modification and application to nervous system diseases.
Yang Y; Ren X; Schluesener HJ; Zhang Z
Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
[TBL] [Abstract][Full Text] [Related]
16. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
17. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469
[TBL] [Abstract][Full Text] [Related]
18. Chemical Modification of Aptamers for Increased Binding Affinity in Diagnostic Applications: Current Status and Future Prospects.
Elskens JP; Elskens JM; Madder A
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630547
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Aptamer: The Prominent Applications and Different Computational Tools for its Design.
Ameri M; Eskandari S; Nezafat N
Curr Pharm Biotechnol; 2021; 22(10):1273-1286. PubMed ID: 33208068
[TBL] [Abstract][Full Text] [Related]
20. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
